Jan 31Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023
Dec 2, 2022Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022
Nov 23, 2022Anavex Life Sciences to Announce Fiscal 2022 Year End Financial Results on Monday November 28, 2022
Nov 8, 2022Anavex Life Sciences to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
Sep 7, 2022Anavex Life Sciences to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
Aug 9, 2022Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 Third Quarter Financial Results
Aug 3, 2022Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday, Aug. 9 2022
Aug 2, 2022Long-lasting Effect of ANAVEX®3-71 Prevents Cognitive Decline in Animal Model of AD at AAIC 2022
Jul 31, 2022Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
May 19, 2022Anavex Life Sciences to Present at the H. C. Wainwright Global Investment Conference 2022
May 3, 2022Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022
Apr 27, 2022Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting
